Your session is about to expire
← Back to Search
Communication Strategies for COVID-19 and Flu Vaccination Rates
N/A
Recruiting
Led By Lila J. Rutten, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7.5 months
Awards & highlights
No Placebo-Only Group
Summary
"This trial will test two strategies to increase the number of adults receiving COVID-19 and influenza vaccines. Despite recommendations, many adults do not get vaccinated. The study will involve adult patients at eight Mayo Clinic
Who is the study for?
This trial is for adults aged 19 or older who are registered with one of eight specific adult primary care practices. It aims to increase the rate at which these individuals receive vaccinations against COVID-19 and influenza.
What is being tested?
The study is testing two methods to boost vaccination rates: sending recommendation letters about vaccines to patients via US mail, and monthly email reminders to clinicians prompting them to vaccinate during visits. The effectiveness will be compared across clinics after six months.
What are the potential side effects?
Since this trial focuses on communication strategies rather than the vaccines themselves, it does not directly involve side effects from interventions being studied.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7.5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7.5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
COVID-19 vaccine uptake
Influenza vaccine uptake
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Patient letter and clinician communicationExperimental Treatment1 Intervention
Each patient will be mailed a letter and each patient's clinician will receive a monthly email communicating information about making a strong recommendation for influenza and COVID-19 vaccination
Group II: No interventionActive Control1 Intervention
No intervention
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,360 Previous Clinical Trials
2,945,461 Total Patients Enrolled
ModernaTX, Inc.Industry Sponsor
121 Previous Clinical Trials
61,470,609 Total Patients Enrolled
Lila J. Rutten, PhDPrincipal InvestigatorMayo Clinic